In addition, the HITT 3-week-ahead intervention appeared to promote BDNF expression and delivery in brain and plasma via the PGC-1α pathway after cerebral ischaemia, which may positively affect mobility in stroke patients (73). The gene discussed is BDNF; the disease is Stroke.